Aquestive Therapeutics (AQST) Stock Price & Financial Analysis
Aquestive Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Aquestive Therapeutics
What is the current stock price for AQST?
As of the latest trading session, AQST stock trades at $4.99. The 52-week range is $2.93–$7.55, with a day range of $4.92–$5.18.
What is the P/E ratio for AQST?
The P/E ratio (Price-to-Earnings) for AQST is shown in the Key Statistics section. This valuation metric helps compare Aquestive Therapeutics, Inc. to industry peers.
Does AQST pay dividends?
Aquestive Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AQST?
Based on 6 analysts, the consensus for AQST is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of AQST?
Aquestive Therapeutics's market capitalization is $611.8M, classifying it as a small-cap company. Aquestive Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.